Annual Cash & Cash Equivalents
$221.12 M
+$172.89 M+358.49%
December 31, 2023
Summary
- As of February 7, 2025, ANIP annual cash & cash equivalents is $221.12 million, with the most recent change of +$172.89 million (+358.49%) on December 31, 2023.
- During the last 3 years, ANIP annual cash & cash equivalents has risen by +$213.26 million (+2711.81%).
- ANIP annual cash & cash equivalents is now at all-time high.
Performance
ANIP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$144.98 M
-$95.13 M-39.62%
September 30, 2024
Summary
- As of February 7, 2025, ANIP quarterly cash and cash equivalents is $144.98 million, with the most recent change of -$95.13 million (-39.62%) on September 30, 2024.
- Over the past year, ANIP quarterly cash and cash equivalents has dropped by -$48.10 million (-24.91%).
- ANIP quarterly cash and cash equivalents is now -39.62% below its all-time high of $240.11 million, reached on June 30, 2024.
Performance
ANIP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ANIP Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +358.5% | -24.9% |
| 3 y3 years | +2711.8% | +114.0% |
| 5 y5 years | +414.1% | +610.2% |
ANIP Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +358.5% | -39.6% | +200.6% |
| 5 y | 5-year | at high | +2711.8% | -39.6% | +1743.6% |
| alltime | all time | at high | >+9999.0% | -39.6% | >+9999.0% |
ANI Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $144.98 M(-39.6%) |
| Jun 2024 | - | $240.11 M(+5.0%) |
| Mar 2024 | - | $228.60 M(+3.4%) |
| Dec 2023 | $221.12 M(+358.5%) | $221.12 M(+14.5%) |
| Sep 2023 | - | $193.08 M(+19.4%) |
| Jun 2023 | - | $161.71 M(+138.7%) |
| Mar 2023 | - | $67.76 M(+40.5%) |
| Dec 2022 | $48.23 M(-51.9%) | $48.23 M(-14.3%) |
| Sep 2022 | - | $56.28 M(-11.2%) |
| Jun 2022 | - | $63.38 M(-17.6%) |
| Mar 2022 | - | $76.91 M(-23.3%) |
| Dec 2021 | $100.30 M(+1175.4%) | $100.30 M(+557.5%) |
| Sep 2021 | - | $15.25 M(-37.1%) |
| Jun 2021 | - | $24.26 M(-3.2%) |
| Mar 2021 | - | $25.07 M(+218.8%) |
| Dec 2020 | $7.86 M(-87.4%) | $7.86 M(-56.1%) |
| Sep 2020 | - | $17.90 M(-35.4%) |
| Jun 2020 | - | $27.70 M(+35.7%) |
| Mar 2020 | - | $20.41 M(-67.2%) |
| Dec 2019 | $62.33 M(+44.9%) | $62.33 M(+4.5%) |
| Sep 2019 | - | $59.67 M(+47.0%) |
| Jun 2019 | - | $40.59 M(+6.2%) |
| Mar 2019 | - | $38.23 M(-11.1%) |
| Dec 2018 | $43.01 M(+38.1%) | $43.01 M(-2.6%) |
| Sep 2018 | - | $44.14 M(-19.7%) |
| Jun 2018 | - | $54.99 M(+5.8%) |
| Mar 2018 | - | $51.97 M(+66.9%) |
| Dec 2017 | $31.14 M(+13.8%) | $31.14 M(+72.7%) |
| Sep 2017 | - | $18.03 M(+115.4%) |
| Jun 2017 | - | $8.37 M(-22.7%) |
| Mar 2017 | - | $10.83 M(-60.4%) |
| Dec 2016 | $27.36 M(-82.3%) | $27.36 M(+69.4%) |
| Sep 2016 | - | $16.16 M(+7.6%) |
| Jun 2016 | - | $15.01 M(-80.7%) |
| Mar 2016 | - | $77.75 M(-49.7%) |
| Dec 2015 | $154.68 M(-8.5%) | $154.68 M(+2.5%) |
| Sep 2015 | - | $150.91 M(-9.5%) |
| Jun 2015 | - | $166.73 M(+0.7%) |
| Mar 2015 | - | $165.56 M(-2.1%) |
| Dec 2014 | $169.04 M(+1422.2%) | $169.04 M(+382.3%) |
| Sep 2014 | - | $35.05 M(-33.8%) |
| Jun 2014 | - | $52.96 M(+3.1%) |
| Mar 2014 | - | $51.37 M(+362.6%) |
| Dec 2013 | $11.11 M(-68.1%) | $11.11 M(+1.6%) |
| Sep 2013 | - | $10.93 M(-13.2%) |
| Jun 2013 | - | $12.59 M(-57.1%) |
| Mar 2013 | - | $29.39 M(-15.5%) |
| Dec 2012 | $34.79 M | $34.79 M(-8.6%) |
| Sep 2012 | - | $38.05 M(-10.3%) |
| Jun 2012 | - | $42.42 M(-14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $49.47 M(-13.5%) |
| Dec 2011 | $57.23 M(+50.0%) | $57.23 M(-17.8%) |
| Sep 2011 | - | $69.60 M(+87.5%) |
| Jun 2011 | - | $37.13 M(-27.7%) |
| Mar 2011 | - | $51.35 M(+34.6%) |
| Dec 2010 | $38.16 M(+27.8%) | $38.16 M(+7.4%) |
| Sep 2010 | - | $35.53 M(-23.4%) |
| Jun 2010 | - | $46.38 M(+12.7%) |
| Mar 2010 | - | $41.16 M(+37.9%) |
| Dec 2009 | $29.86 M(+153.9%) | $29.86 M(+126.7%) |
| Sep 2009 | - | $13.17 M(+120.0%) |
| Jun 2009 | - | $5.99 M(-41.1%) |
| Mar 2009 | - | $10.16 M(-13.6%) |
| Dec 2008 | $11.76 M(-24.8%) | $11.76 M(+106.3%) |
| Sep 2008 | - | $5.70 M(-44.8%) |
| Jun 2008 | - | $10.33 M(-21.2%) |
| Mar 2008 | - | $13.11 M(-16.2%) |
| Dec 2007 | $15.65 M(+104.5%) | $15.65 M(-38.4%) |
| Sep 2007 | - | $25.40 M(-7.2%) |
| Jun 2007 | - | $27.38 M(+142.5%) |
| Mar 2007 | - | $11.29 M(+47.5%) |
| Dec 2006 | $7.65 M(+2364.2%) | $7.65 M(+1990.1%) |
| Sep 2006 | - | $366.20 K(+174.1%) |
| Jun 2006 | - | $133.60 K(+90.3%) |
| Mar 2006 | - | $70.20 K(-77.4%) |
| Dec 2005 | $310.60 K(-73.5%) | $310.60 K(+22.2%) |
| Sep 2005 | - | $254.10 K(-33.0%) |
| Jun 2005 | - | $379.50 K(+575.3%) |
| Mar 2005 | - | $56.20 K(-95.2%) |
| Dec 2004 | $1.17 M(-87.2%) | $1.17 M(-94.3%) |
| Sep 2004 | - | $20.58 M(-10.4%) |
| Jun 2004 | - | $22.97 M(+178.0%) |
| Mar 2004 | - | $8.26 M(-9.5%) |
| Dec 2003 | $9.13 M(+87.0%) | $9.13 M(-12.1%) |
| Sep 2003 | - | $10.40 M(+345.2%) |
| Jun 2003 | - | $2.33 M(-31.6%) |
| Mar 2003 | - | $3.41 M(-30.1%) |
| Dec 2002 | $4.88 M(+8.5%) | $4.88 M(-7.1%) |
| Sep 2002 | - | $5.26 M(+208.5%) |
| Jun 2002 | - | $1.70 M(-46.1%) |
| Mar 2002 | - | $3.16 M(-29.8%) |
| Dec 2001 | $4.50 M(+72.4%) | $4.50 M(-24.7%) |
| Sep 2001 | - | $5.98 M(+25.0%) |
| Jun 2001 | - | $4.78 M(-8.4%) |
| Mar 2001 | - | $5.22 M(+99.9%) |
| Dec 2000 | $2.61 M(-50.5%) | $2.61 M(-19.3%) |
| Sep 2000 | - | $3.23 M(-3.9%) |
| Jun 2000 | - | $3.37 M(-30.1%) |
| Mar 2000 | - | $4.81 M |
| Dec 1999 | $5.27 M(+85.6%) | - |
| Dec 1998 | $2.84 M | - |
FAQ
- What is ANI Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is ANI Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is ANI Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of ANIP is $221.12 M
What is the all time high annual cash & cash equivalents for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual cash & cash equivalents is $221.12 M
What is ANI Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, ANIP annual cash & cash equivalents has changed by +$172.89 M (+358.49%)
What is ANI Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ANIP is $144.98 M
What is the all time high quarterly cash and cash equivalents for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly cash and cash equivalents is $240.11 M
What is ANI Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, ANIP quarterly cash and cash equivalents has changed by -$48.10 M (-24.91%)